IVF

Op-Ed: When Maternal Health Goes Wrong

Retrieved on: 
Tuesday, April 16, 2024
Education, MedStar Health, Mortality, Health equity, Pregnancy, Woman, Hospital, Statistics, Human services, IGS, Death, Abortion, Infant, Life, IVF, Black, Federation, Communication, White, Senior counsel, Organization, Physician, Pre-eclampsia, Mother, Child, Fertilisation, HBCU, COVID-19, Disease, Birth control

WASHINGTON, April 16, 2024 /PRNewswire/ -- The best day of your life shouldn't be the most fearful. Women like me, Abby Phillips, Elain Welteroth, and others know what it means to manifest the life we've always dreamed of. But when it comes to being a mom, income doesn't matter. For Black and Brown women, our greatest dream can often be our worst nightmare because, regardless of our station, when it comes to healthy births for mothers and infants, the statistics are staggering: Black women are three times as likely to die from pregnancy-related causes as are White women.

Key Points: 
  • You see, for me and many other Black women, maternal health and pregnancy are bittersweet.
  • For Black women, whether they are from the inner city or highly educated with high net worths, maternal health is the great equalizer beyond income.
  • Organizations such as Health and Human Services, the Center for Disease Control, and the National Institute of Health, Health Resources, and Services Administration have much work to do.
  • Continued investment in maternal health, addressing inequalities, and ensuring that all women have resources are easy fixes.

Stork Club Reproductive Care is Now Available in 100 Countries Globally, With Innovative Direct Pay Across 8,000 In-Network Providers

Retrieved on: 
Tuesday, April 16, 2024
Health, Stork Club, Conference, IVF, Cryopreservation, Child, The Stork Club, City centre, The Conference Board, SAN, Nightclub

SAN FRANCISCO, April 16, 2024 /PRNewswire/ -- Stork Club, a pioneering enterprise reproductive care benefits solution, announced today that employers and their covered employees with Stork Club global coverage can now access care in 100 countries, in addition to the U.S., with access to critical reproductive and family-building care at over 8,000 providers across the globe. 

Key Points: 
  • Instead, Stork Club pays in-network providers directly, removing an unnecessary step, reducing cost, and streamlining member experience.
  • SAN FRANCISCO, April 16, 2024 /PRNewswire/ -- Stork Club , a pioneering enterprise reproductive care benefits solution, announced today that employers and their covered employees with Stork Club global coverage can now access care in 100 countries, in addition to the U.S., with access to critical reproductive and family-building care at over 8,000 providers across the globe.
  • Additionally, early this year, Stork Club successfully implemented a Direct Pay approach globally, enabling a streamlined member experience where members don't have to use virtual or physical benefits cards to prepay for their care.
  • As part of its continuous development of enterprise-ready care, Stork Club also now offers dedicated Care Partners across the globe.

Breakthrough whole genome report for embryos created during IVF delivers 100x data for parents, peer reviewed validation published

Retrieved on: 
Monday, April 15, 2024
Risk, Pregnancy, Birth, WGS, Parent, IVF, Genetics, DNA, DSM-IV codes, Harvard Medical School, Genome, Multimedia, Molina Healthcare, Cancer, SAN, Interest, Vaccine

Orchid published its clinical validation of whole genome embryo screening, a step forward in IVF and genetic screening.

Key Points: 
  • Orchid published its clinical validation of whole genome embryo screening, a step forward in IVF and genetic screening.
  • Until now, standard genetic screening for embryos read less than 1% of an embryo's genome, which left most conditions undetected until pregnancy, birth, or even through childhood into adulthood.
  • Then, it could take years to accurately diagnose these conditions, causing harm, stress, and cost to impacted individuals and their families.
  • Now, Orchid have proven their ability to use whole-genome sequencing (WGS) to successfully read >99% of an embryo's genome, providing 100x more data than traditional tests.

Amid threats to IVF, National Infertility Awareness Week® Brings Awareness Activities Across the Country

Retrieved on: 
Monday, April 15, 2024
CVS, Fertility, NIAW, Social media, Woman, Infertility, Human services, Merck Serono, Encompass, IVF, Family, Ferring Pharmaceuticals, Legislation, Movement, Face, First, The Cooper Companies, Birth control

MCLEAN, Va., April 15, 2024 /PRNewswire-PRWeb/ -- RESOLVE: The National Infertility Association (RESOLVE) will recognize National Infertility Awareness Week®, April 21 through April 27, 2024. The movement brings together millions of Americans who want to remove the stigmas and barriers that stand in the way of building families. RESOLVE will rally the infertility community to share their stories in an effort to raise awareness about the threats to family building options like IVF, the lack of access to family building options and the need for emotional support for the 1 in 6 people who will face infertility. #LeaveYourMark is a message found on the official NIAW website and throughout RESOLVE's social media campaigns.

Key Points: 
  • RESOLVE: The National Infertility Association will recognize National Infertility Awareness Week®, April 21 through April 27, 2024.
  • The movement brings together millions of Americans who want to remove the stigmas and barriers that stand in the way of building families.
  • MCLEAN, Va., April 15, 2024 /PRNewswire-PRWeb/ -- RESOLVE: The National Infertility Association (RESOLVE) will recognize National Infertility Awareness Week® , April 21 through April 27, 2024.
  • The movement brings together millions of Americans who want to remove the stigmas and barriers that stand in the way of building families.

Institute for Human Reproduction (IHR), a Leading Fertility Center in the Midwest with Offices in IL, IN, and WI, Honors National Infertility Awareness Week with a Free IVF Cycle Lottery

Retrieved on: 
Monday, April 15, 2024
IHR, NIAW, Lottery, Infertility, AMH, Insurance, Reproduction, History, IVF, Family, Journey, Physician, Pinnacle, Movement, Birth control

This initiative is designed to shine a light on infertility issues while offering hope and support to those struggling to build their families.

Key Points: 
  • This initiative is designed to shine a light on infertility issues while offering hope and support to those struggling to build their families.
  • Participants must also like the Institute for Human Reproduction on Facebook and follow @IHRfertility on Instagram.
  • The lucky recipient will receive a free IVF cycle, offering a significant opportunity towards achieving their dream of family.
  • For more information on the free IVF cycle Lottery, including detailed eligibility criteria and the entry form, please visit IHRfertility.com/ivf-lottery .

The Stork Foundation for Infertility Announces Annual "Brunch for Hope" Event in Chicago to Kick-Off National Infertility Awareness Week

Retrieved on: 
Thursday, April 11, 2024
Education, Jenn Grinels, M.D, Morgan Stanley, REI, Fertility, VIP, Parent, Obstetrics, IVF, Gynaecology, Rush University Medical Center, FACOG, Birth control

CHICAGO, April 11, 2024 /PRNewswire/ -- The Stork Foundation for Infertility, a non-profit offering financial aid to those facing infertility challenges with limited resources; is delighted to announce its second annual Brunch for Hope. The event is scheduled for Sunday, April 21, at Revel Motor Row. Serving as the kickoff for National Infertility Awareness Week, the brunch helps bring supporters together to raise funds and promote awareness for the infertility community.

Key Points: 
  • Serving as the kickoff for National Infertility Awareness Week, the brunch helps bring supporters together to raise funds and promote awareness for the infertility community.
  • Through the supportive community, and those impacted by infertility this event continues to serve as a place to cultivate awareness and equitable support."
  • "We are delighted to start off National Infertility Awareness Week with great passion, launching our second annual Brunch for Hope to honor the resilience of infertility warriors.
  • "At the Stork Foundation, we recognize and understand that infertility transcends mere medical challenges; it portrays a struggle for a treasured dream.

Family Source Consultants Partners with Worth the Wait Charity to Support Young Adult Cancer Patients & Survivors Pursuing Parenthood

Retrieved on: 
Thursday, April 11, 2024
Family, Cancer, Worth, Hysterectomy, Wait, Hope, Infertility, Reproduction, Fertility preservation, FSC, Uterine cancer, Insurance, Partnership, Fertility, Testicular cancer, Parent, IVF, Survivor, Patient, Food, Music, Consultant, Young adult, Birth control

CHICAGO, April 10, 2024 /PRNewswire-PRWeb/ -- This coming September, leading surrogacy agency Family Source Consultants (FSC) will serve as a main sponsor for a fundraising event in support of Worth the Wait Charity. The non-profit organization is dedicated to assisting young adult cancer patients and survivors start their family, many of whom struggle with infertility following treatment. Worth the Wait Charity provides grants to help offset the costs of building families through fertility preservation, adoption, fertility treatments and surrogacy.

Key Points: 
  • This support will make a world of difference in helping ease the financial burden for young adult cancer survivors pursuing parenthood.
  • All proceeds from Jeep Off Cancer will directly support Worth the Wait Charity's mission of aiding young adult cancer patients and survivors on their journey to parenthood.
  • This support will make a world of difference in helping ease the financial burden for young adult cancer survivors pursuing parenthood."
  • "Family Source Consultants couldn't be more eager to support Worth the Wait Charity's Jeep Off Cancer event," said Swiderski.

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

Retrieved on: 
Thursday, April 4, 2024
Foreign policy, Empire, Infertility, Face, Disease, Empathy, Education, IVF, Fertility, Evite, Family, Movement, Birth control

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE : The National Infertility Association today announced a series of nationwide events to commemorate National Infertility Awareness Week (April 21-27, 2024).

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE : The National Infertility Association today announced a series of nationwide events to commemorate National Infertility Awareness Week (April 21-27, 2024).
  • "National Infertility Awareness Week sheds light on the profound impact of infertility, promoting compassion, empathy, and solidarity for the countless individuals struggling to build their family," said Pete Anevski, CEO of Progyny.
  • This will be the third consecutive year the Empire State Building will be lit to support those faced with infertility.
  • "Being an advocate for others navigating their journey, I am deeply honored to participate in National Infertility Awareness Week alongside Progyny and RESOLVE,” says Iskra Lawrence.

Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023

Retrieved on: 
Wednesday, March 27, 2024
Financial statement, Growth, Infertility, International, IVF, Travel, EDT, Acquisition, Laboratory, Consumables, Adjustment, Investment, Depreciation, Analysis, Marketing, Hand, Bookkeeping

Results of Operations for the Year ended December 31, 2023

Key Points: 
  • Results of Operations for the Year ended December 31, 2023
    Hamilton Thorne sales increased 16% to $67,225,476 for the year-ended December 31, 2023, an increase of $9,047,409 from $58,178,067 during the previous year.
  • Consumable sales in 2023 outpaced the Company’s overall growth despite being affected by the recall of certain products by one of the Company’s contract manufacturers.
  • We are expecting first quarter 2024 reported revenues of between $19.0 to 19.4M, with organic growth for the quarter of approximately 8%.
  • Financial Statements and accompanying Management Discussion and Analysis for the periods are available on www.sedar.com and the Hamilton Thorne website.

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

Retrieved on: 
Thursday, March 21, 2024
ART, Obstetrics, Fireside, Gynaecology, Infertility, Case Western Reserve University, IVF, Climate, University, Woman, Reproductive biology, FDA

Those interested in attending the event, which will be held virtually TODAY, March 21, 2024 at 1PM ET, may register here.

Key Points: 
  • Those interested in attending the event, which will be held virtually TODAY, March 21, 2024 at 1PM ET, may register here.
  • will focus on the current treatment options in the infertility services market, including Femasys’ FDA-authorized FemaSeed device for intratubal insemination.
  • Ms. Lee-Sepsick is the founder of Femasys and has nearly three decades of experience as a senior executive in the medical technology industry.
  • She is the lead inventor of the technologies at Femasys and remains committed to advancing much needed technology in women’s health.